{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:40:55Z","timestamp":1760060455401,"version":"build-2065373602"},"reference-count":23,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Geisinger Academic Clinical Research Center","award":["01, 03, 05"],"award-info":[{"award-number":["01, 03, 05"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>The small (N = 102) prospective study by Bar-Sela and colleagues at Emek Medical Center in Israel) regarding diminished efficacy of immunotherapy in the setting of cannabis use would be an important discovery which could theoretically benefit the outcomes of oncology patients if verified by independent research teams, including by basic scientists. However, if this finding was spurious, clinical practice guidelines could recommend that oncology patients receiving immunotherapies be erroneously denied an evidence-based treatment for pain and chemotherapy-induced nausea and vomiting. Our full-length manuscript identified dozens of instances of unverifiable statistical information and even errors in arithmetic in this report. More briefly, our concerns regarding this well-cited (123 times) paper are as follows: (1) non-verifiable non-parametric statistics, including some that would change the statistical inferences; (2) difficulties with determining percentages; (3) switching from two-tailed tests in the Methods to one-tailed in the Results; (4) engaging in the unusual practice of floor rounding but not reporting this in the Methods; and (5) not reporting smoking, which could be a key confound. These concerns are serious errors that undermine the validity of the results and invalidate the conclusions that can be drawn from this prospective study about cannabis and immunotherapy.<\/jats:p>","DOI":"10.3390\/cancers17172754","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:09:53Z","timestamp":1756080593000},"page":"2754","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comment on Bar-Sela et al. Cannabis Consumption Used by Cancer Patients During Immunotherapy Correlates with Poor Clinical Outcome. Cancers 2020, 12, 2447"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2295-445X","authenticated-orcid":false,"given":"Brian J.","family":"Piper","sequence":"first","affiliation":[{"name":"Department of Medical Education, Geisinger College of Health Sciences, Scranton, PA 18509, USA"},{"name":"Center for Pharmacy Innovation & Outcomes, Geisinger College of Health Sciences, Danville, PA 17821, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8416-9159","authenticated-orcid":false,"given":"Duncan X.","family":"Dobbins","sequence":"additional","affiliation":[{"name":"Center for Pharmacy Innovation & Outcomes, Geisinger College of Health Sciences, Danville, PA 17821, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0047-7178","authenticated-orcid":false,"given":"Jason","family":"Graham","sequence":"additional","affiliation":[{"name":"Department of Mathematics, University of Scranton, Scranton, PA 18510, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M.","family":"Churilla","sequence":"additional","affiliation":[{"name":"Department of Medical Education, Geisinger College of Health Sciences, Scranton, PA 18509, USA"},{"name":"Northeast Radiation Oncology Centers, Dunmore, PA 18512, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6667-0096","authenticated-orcid":false,"given":"Michael","family":"Bordonaro","sequence":"additional","affiliation":[{"name":"Department of Medical Education, Geisinger College of Health Sciences, Scranton, PA 18509, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Bar-Sela, G., Cohen, I., Campisi-Pinto, S., Lewitus, G.M., Oz-Ari, L., Jehassi, A., Peer, A., Turgeman, I., Vernicova, O., and Berman, P. (2020). Cannabis consumption used by cancer patients during immunotherapy correlates with poor clinical outcome. Cancers, 12.","DOI":"10.3390\/cancers12092447"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1371\/journal.pmed.0020124","article-title":"Why most published research findings are false","volume":"2","author":"Ioaniddis","year":"2005","journal-title":"PLoS Med."},{"key":"ref_3","first-page":"202","article-title":"MASCC guideline: Cannabis for cancer-related pain and risk of harms and adverse events","volume":"31","author":"To","year":"2023","journal-title":"Support. Care Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1200\/JCO.23.02596","article-title":"Cannabis and cannabinoids in adults with Cancer: ASCO Guidelines","volume":"42","author":"Braun","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_5","unstructured":"National Academies of Sciences (2017). The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research, National Academies of Sciences."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Piper, B.J., Tian, M., Saini, P., Higazy, A., Graham, J., Carbe, C.J., and Bordonaro, M. (2024). Immunotherapy and cannabis: A harmful drug interaction or Reefer Madness?. Cancers, 16.","DOI":"10.1101\/2024.01.26.24301817"},{"key":"ref_7","unstructured":"GraphPad Prism (2025, July 17). Analyze a 2x2 Contingency Table. Available online: https:\/\/www.graphpad.com\/quickcalcs\/contingency2\/."},{"key":"ref_8","unstructured":"(2024, December 21). Wikipedia. Available online: https:\/\/en.wikipedia.org\/wiki\/Floor_and_ceiling_functions."},{"key":"ref_9","unstructured":"National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health (2014). The Health Consequences of Smoking\u201450 Years of Progress: A Report of the Surgeon General."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jtho.2022.03.008","article-title":"Ignoring the obvious: Smoking cessation improves survival","volume":"17","author":"Evans","year":"2022","journal-title":"J. Thorac. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e021611","DOI":"10.1136\/bmjopen-2018-021611","article-title":"Smoking as a risk factor for lung cancer in women and men: A systematic review and meta-analysis","volume":"8","author":"Taylor","year":"2018","journal-title":"BMJ Open"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e2354751","DOI":"10.1001\/jamanetworkopen.2023.54751","article-title":"Smoking status and survival in patients with early stage primary cutaneous melanoma","volume":"7","author":"Jackson","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"6633","DOI":"10.1007\/s13277-014-1862-8","article-title":"The impact of smoking on survival in renal cell carcinoma: A systematic review and meta-analysis","volume":"35","author":"Xu","year":"2014","journal-title":"Tumor Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/spcare-2024-005124","article-title":"Medical cannabis use in young adults with cancer: A self-reported survey study","volume":"14","author":"Halpern","year":"2024","journal-title":"BMJ Support. Palliat. Care"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1634\/theoncologist.2018-0383","article-title":"Cannabis impacts tumor response rate to nivolumab in patients with advanced malignancies","volume":"24","author":"Taha","year":"2019","journal-title":"Oncologist"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/jrsm.1408","article-title":"\u201cstatcheck\u201d: Automatically detect statistical reporting inconsistencies to increase reproducibility of meta-analyses","volume":"11","author":"Nuijten","year":"2020","journal-title":"Res. Synth. Methods"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejca.2022.11.022","article-title":"The use of medical cannabis concomitantly with immune checkpoint inhibitors in non-small cell lung cancer: A sigh of relief?","volume":"180","author":"Waissengrin","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"ref_18","unstructured":"Tikun (2025, August 07). Our Strains. Available online: https:\/\/www.tikun-olam.info\/our-Strains\/."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/02791072.2017.1390179","article-title":"Mother of Berries, ACDC, or Chocolope: Examination of the strains used by medical cannabis patients in New England","volume":"50","author":"Piper","year":"2018","journal-title":"J. Psychoact. Drugs"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.1158\/1538-7445.AM2024-5548","article-title":"Abstract 5548: Cannabidiol enhances efficacy of atezolizumab via upregulation of PD-L1 expression by cGAS-STING pathway in triple negative breast cancer cells","volume":"84","author":"Kim","year":"2024","journal-title":"Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/s41416-021-01259-3","article-title":"A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma","volume":"124","author":"Twelves","year":"2021","journal-title":"Brit. J. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/EDE.0b013e31818131e7","article-title":"Why most discovered true associations are inflated","volume":"19","author":"Ionnidis","year":"2008","journal-title":"Epidemiology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3390\/onco4040021","article-title":"Phytocannabinoids as chemotherapy adjuncts\u2014A review for users","volume":"4","author":"Nahler","year":"2024","journal-title":"Onco"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/17\/2754\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:34:57Z","timestamp":1760034897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/17\/2754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,23]]},"references-count":23,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["cancers17172754"],"URL":"https:\/\/doi.org\/10.3390\/cancers17172754","relation":{},"ISSN":["2072-6694"],"issn-type":[{"type":"electronic","value":"2072-6694"}],"subject":[],"published":{"date-parts":[[2025,8,23]]}}}